3Bast RC,Klug TL,St John E,et al.A radioimmunoassay using a monoclonal antibody to monitor the course of epithelial ovarian cancer[J].N Engl J Med,1983,309(15):883-887.
4Hogdall E.Cancer antigen 125 and prognosis[J].Curr Opin Obstet Gynecol,2008,20(1):4-8.
5Nagele F,Petru E,Medl M,et al.Preoperative CA 125:An independent prognostic factor in patients with stage I epithelial ovarian cancer[J].Obstet Gynecol,1995,86(2):259-264.
6Kraemer S,Jaeger WH,Lang N.Growth regulation effects of gonadotropin induced steroidogenic response in human ovarian cancer[J].Anticancer Res,2001,21(3):2005-2010.
7Koji T,Fumitaka K,Kiyosumi S,et al.Clinical value of CA125,CA19-9,CEA,CA72-4 and TPA in borderline ovarian tumor[J].Gynecologic Oncol,1996,62(1):67-72.
8Digant G,Christopher GL.Role of CA125 in predicting ovarian cancer survival-a review of the epidemiological literature[J].J Ovarian Res,2009,9(2):13.
9Munstedt K,Steen J,Knauf AG,et al.Steroid hormone receptors and long term survival in invasive ovarian cancer[J].Cancer,2000,89(8):783-791.
10Luo P,He E,Eriksson S,et al.Thymidine kinase activity in serum of renal cell carcinoma patients is a useful prognostic marker[J].Eur J Cancer Prev,2009,18(3):220-224.
